| Literature DB >> 32641857 |
Giovanna Lima de Oliveira1, Adriana Hernandez Marques1, Vanessa Ferrari da Fonseca1, Beatriz Augusta Pozzolo1, Fernanda Panacioni1, Taís Capucho Santos1, Amanda Archeleiga Guedes1, Aurenzo Gonçalves Mocelin1, Renata Labronici Bertin1,2, Anderson Zampier Ulbrich3,4.
Abstract
The aim of this study was to investigate whether the use of handrail support during maximal exercise treadmill testing (ETT) would interfere in cardiac autonomic modulation kinetics when compared to not using handrail support. The hypothesis of overestimation in cardiac autonomic dynamics when the ETT is performed using handrail was tested. Thirty-five undergraduates (21.08 ± 2.98 years old) of both sexes, volunteered to undertake two ETT under the Ellestad protocol, in non-consecutive days. The first test (T1) was performed with handrail support and, after 7 days, the second test was performed (T2) without the support. Autonomic function was measured by heart rate variability (HRV) during both tests and resting. Estimated value of peak oxygen uptake (VO2) was 22.4% (p < 0.0001) higher in T1 when compared to T2. Overall, parasympathetic pathway was deactivated earlier in T2 than in T1, with NNxx measures variating in T1 from 10.74 ± 14.59 (ms) and in T2 from 3.48 ± 3.79 (ms). In stage two, mean values of HF in T2 corresponded to 32% of values in T1. Stage three presented a difference of 60% (p < 0.014) in LF between means reached in T1 and T2. Lastly, the association of LF and VO2 persisted longer in T1 stages than in T2 and was verified in early stages (S2 and S3) of both ETTs. Our findings suggest that parasympathetic influences on HR were slightly prolonged during ETT when subjects hold onto the treadmill.Entities:
Mesh:
Year: 2020 PMID: 32641857 PMCID: PMC7343795 DOI: 10.1038/s41598-020-68155-3
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Descriptive features of subjects and cardiopulmonary and hemodynamic responses in different ETTs.
| Features | N = 35 |
|---|---|
| Age (years) | 21.08 ± 2.98 |
| Men, n (%) | 19 (54.3) |
| Weight (kg) | 66.66 ± 13.27 |
| Height (cm) | 169.1 ± 9.4 |
| BMI (kg/m2) | 23.11 ± 3.09 |
| WC (cm) | 76.5 ± 8.1 |
| Sum DC (mm) | 108.38 ± 35.1 |
| %F (%) | 18.80 ± 5.22 |
| WHR | 0.45 ± 0.03 |
T1 Test 1 (holding on to the treadmill), T2 Test 2 (not holding on to the treadmill), BMI Body Mass Index, WC waist circumference, %F percentage of fat, WHR waist height ratio, HR rest resting heart rate, HRmax maximum heart rate, SBPrest systolic blood pressure at rest, DBPrest diastolic blood pressure at rest, SBP max maximum systolic blood pressure in the test, DBP max maximum diastolic blood pressure in the test, VOpeak Maximum VO2.
Values reported in mean ± standard deviation; *p < 0.05.
Figure 1Hemodynamic and cardiopulmonary responses during different methods of ETT. (A) Graphical analysis of the VO2 for each test in T1 and T2, in which each line corresponds to a subject that connects the points representing the ETT (T1 and T2). (B–D) represent the graphs of mean HR, SBP and DBP at each stage of the T1 and T2 tests. ETT exercise treadmill testing stages without recovery, REC time interval of post-ETT recovery (3 min); Baseline rest; S1 stage one, S2 stage two, S3 stage three, S4 stage four; S5 stage five, S6 stage six. The values are represented by mean and standard deviation at each stage. The numbers of subjects that completed each stage for T1 and T2, respectively (S1: n = 35, 35; S2: n = 35, 35; S3: n = 35, 35; S4: n = 30, 28; S5: n = 21, 12; S6: n = 11, 1; S7: n = 3, 0). *p < 0.05: * indicates difference between groups in the specific stage.
Overall evaluation, disregarding the stages, of the HRV variables at rest, holding and not holding on to the handrails of the treadmill.
| Rest | T1 | T2 | ||
|---|---|---|---|---|
| RR (ms) | 834.8 ± 101.7 | 385.68 ± 71.6 | 369.8 ± 23.2 | 0.388 |
| SDNN (ms) | 51.88 ± 20.97 | 10.32 ± 6.26 | 10.15 ± 8.36 | 0.922 |
| RMSSD (ms) | 52.47 ± 26.53 | 9.34 ± 6.9 | 9.02 ± 7.1 | 0.826 |
| NNxx (beats) | 177.57 ± 106.94 | 10.74 ± 14.59 | 3.48 ± 3.79* | 0.005 |
| VLF (ms2) | 176.14 ± 146.73 | 11.94 ± 10.18 | 13.14 ± 11.85 | 0.629 |
| HF (ms2) | 1,296.4 ± 1,307.8 | 38.28 ± 51.37 | 22.00 ± 27.59* | 0.050 |
| LF (ms2) | 1,336.6 ± 1,175.06 | 66.05 ± 56.79 | 55.17 ± 48.84 | 0.265 |
RR RR interval, SDNN standard deviation of all normal RR intervals, RMSSD root mean square of successive squared differences between adjacent normal RRs, NNxx number of interval differences of successive intervals NN greater than xx = 39 40, 50 ms, VLF very low frequency component, HF high frequency component, LF low frequency component, LF/HF ratio between LF and HF.
*p < 0.05.
#Paired comparison between T1 and T2; values reported in mean ± standard deviation (n = 35).
Figure 2Component dynamics of HRV frequency during ETT. Graphical analysis at each stage of the tests T1 and T2 for (A) the high frequency component (HF), (B) the low frequency component, (C) the ratio between LF and HF, and (D) very low frequency. The considered values correspond to the mean of all the tests performed in each execution mode, for each stage. ETT exercise treadmill testing stages without recovery, REC to the recovery period of the test (3 min), S1 stage one, S2 stage two, S3 stage three, S4 stage four, S5 stage five, S6 stage six, S7 stage seven. The values are represented by mean and standard deviation at each stage. The numbers of subjects that completed each stage for T1 and T2, respectively (S1: n = 35, 35; S2: n = 35, 35; S3: n = 35, 35; S4: n = 30, 28; S5: n = 21, 12; S6: n = 11, 1; S7: n = 3, 0). *p < 0.05. *Indicates difference between groups in the specific stage.
Association of VO2 with the components of HRV determined in the stages of the different ETT.
| S1 β (95% CI) | S2 β (95% CI) | S3 β (95% CI) | S4 β (95% CI) | S5 β (95% CI) | REC β (95% CI) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VLF | 0.033 (− 0.071; 0.137) | 0.524 | 0.094 (− 0.507; 0.695) | 0.752 | 0.545 (− 1.453; 0.363) | 0.230 | 3.939 (0.812; 7.066) | 0.015* | − 3.355 (− 20.465; 13.754) | 0.684 | − 0.345 (− 1.123; 0.432) | 0.372 |
| LF | 0.013 (0.001; 0.025) | 0.032* | 0.028 (− 0.003; 0.058) | 0.073 | 0.139 (− 0.022; − 0.255) | 0.021* | 0.597 (− 2.491; 3.666) | 0.698 | 1.548 (− 6.780; 9.875) | 0.701 | − 0.087 (− 0.816; 0.641) | 0.808 |
| HF | − 0.014 (− 0.053; 0.026) | 0.481 | − 0.017 (− 0.060; 0.026) | 0.426 | − 0.185 (− 0.528; 0.158) | 0.281 | 0.424 (− 0.341; 1.189) | 0.265 | 1.648 (0.144; 3.153) | 0.033* | 0.132 (− 0.118; 0.381) | 0.290 |
| VLF | 0.021 (− 0.041; 0.083) | 0.497 | 0.168 (− 0.506; 0.171) | 0.320 | 1.088 (− 0.360; 2.536) | 0.135 | 0.469 (− 0.668; 1.607) | 0.404 | 2.031 (− 6.786; 10.848) | 0.610 | − 0.244 (− 0.381; − 0.107) | 0.001* |
| LF | 0.012 (0.002; 0.021) | 0.020* | 0.056 (0.014; 0.098) | 0.011* | 0.264 (− 0.713; 0.186) | 0.241 | − 0.612 (− 1.693; 0.469) | 0.255 | − 1.110 (− 4.783; 2.563) | 0.511 | − 0.134 (− 0.331; 0.064) | 0.178 |
| HF | − 0.016 (− 0.048; 0.015) | 0.293 | − 0.051 (− 0.133; 0.032) | 0.219 | 0.108 (− 0.070; 0.285) | 0.227 | 0.471 (− 2.062; 3.004) | 0.705 | 0.446 (− 1.039; 1.931) | 0.518 | 0.010 (− 0.176; 0.158) | 0.906 |
Values reported in calculated value of β (minimum value − maximum value). The value of β corresponds to how many ml kg−1 min−1 are added to VO2 when a unit of the HRV variable is increased. The analysis was performed only including values from S1 to S5 because the number of subjects who participate of S6 and S7 were not sufficient to obtain statistically significant results.
VLF very low frequency component, HF: high frequency component, LF: low frequency component, L/H ratio between LF and HF, REC to recovery period of the test (3 min), S1 stage one, S2 stage two, S3 stage three, S4 stage four, S5 stage five, REC recovery time to ST with a 3-min duration.
*p < 0.05.